By providing independent psychedelic-specialist CRO services, Clerkenwell will accelerate the adoption of these treatments across Europe.
The team are passionate about putting patients at the centre of clinical trial design and delivering gold standard therapy protocols.
The team are passionate about putting patients at the centre of clinical trial design and delivering gold standard therapy protocols.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $2.33M
Founded date: 2020
Investors 4
| Date | Name | Website |
| 04.08.2022 | Syndicate ... | syndicater... |
| - | Moonstone | moonstone.... |
| 10.07.2026 | SPRIM Glob... | sprim.net |
| - | Exceptiona... | exceptiona... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.10.2022 | Seed | $2.33M | - |
Mentions in press and media 8
| Date | Title | Description |
| 13.09.2023 | Norrsken Foundation launches psychedelic science initiative for mental health | Norrsken Foundation has today announced the launch of Norrsken Mind: Psychedelic Science Initiative, a foundation focused on the treatment of mental health through psychedelic substances. Norrsken Mind has raised over €3 million and says th... |
| 15.05.2023 | Specialist Contract Research Organizations Ink Transatlantic Partnership to Facilitate Psychedelic Clinical Research | We have seen the psychedelic segment evolve from concept to now a well-funded reality.” — C.G. (Chip) Gillooly - CEOST. PETERSBURG, FLORIDA, USA, May 15, 2023/EINPresswire.com/ -- Drug developers will now be able to find the most suitable r... |
| 27.03.2023 | Here are the 15 hottest startups in the psychedelics industry, according to top investors | From left: Sherry Rais, a cofounder and the CEO of Enthea; Mark Rus, the CEO of Delix Therapeutics; Jackie von Salm, a cofounder and the CSO of Psilera; Jimmy Qian, a cofounder and the president of Osmind. Sherry Rais/Enthea; Mark Rus/Delix... |
| 10.10.2022 | Clerkenwell Closes £2.1M Seed Funding | Clerkenwell Health, a London, UK-based clinical psychedelics startup, raised £2.1M in Seed funding. Backers included Lionheart Ventures, Convergence Partners, and Exceptional Ventures. The company intends to use the funds to support the ope... |
| 10.10.2022 | Clerkenwell Health raises £2.1M to test the new wave of psychedelics treatments | Clerkenwell Health, a psychedelic-specialist clinical research organisation, has raised £2.1 million in seed funding, bringing the total to date up to £2.5 million, which will be used to get the London-based startup fully operational. Inves... |
| 09.05.2022 | London psychedelic specialist to roll out clinical trials to tackle mental health issues | There has been a huge rise in people contacting mental health services in recent years globally. In the U.K., there has never been a more desperate need to identify new and innovative treatments in addressing mental health with 1 in 10 cons... |
| - | London psychedelic specialist to roll out clinical trials to tackle mental health issues | There has been a huge rise in people contacting mental health services in recent years globally. In the U.K., there has never been a more desperate need to identify new and innovative treatments in addressing mental health with 1 in 10 cons... |
| - | Clerkenwell Health | “Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.” |